Zacks Investment Research, Inc. resumes coverage for ENUMERAL BIOMEDICA with BUY recommendation. BY Investars Analyst Actions - private — 12:18 PM ET 01/19/2018
On January 19, 2018 Zacks Investment Research, Inc. resumed coverage for ENUMERAL BIOMEDICA with a BUY recommendation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.